There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
2965.55 Cr.Face value
2.00Book value
405.14Div. yield
0.000P/E ratio
24.96P/B ratio
0.47Debt/Eq.
0.36Market Cap
2965.55 Cr.Face value
2.00Book value
405.14Div. yield
0.00%P/E ratio
24.96P/B ratio
0.47Debt/Eq.
0.36
| Mar 26 | Dec 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 59.32% | 59.32% | 0.00% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
Dishman Carbogen Amcis Limited (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has 
The company's core business is CDMO (Contract Development and Manufacturing Organisation), which provides end-to-end solutions for pharmaceutical companies. It also has a Marketable Molecules segment that includes speciality chemicals, vitamins, and disinfectants.
. Dishman Carbogen Amcis operates in 6 countries: India, Switzerland, the UK, France, China, and the Netherlands. Its network includes 25 manufacturing facilities and 28 R&D labs.
